BMY Bristol Myers Squibb Co

Price (delayed)

$72.4

Market cap

$153.93B

P/E Ratio

23.43

Dividend/share

$2.19

EPS

$3.09

Enterprise value

$185.3B

Bristol Myers Squibb is an American pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, ...

Highlights
BMY's debt is down by 13% year-on-year and by 7% since the previous quarter
Bristol Myers Squibb's gross profit has increased by 5% YoY
The quick ratio has decreased by 16% YoY and by 8% QoQ
Bristol Myers Squibb's equity has decreased by 12% YoY

Key stats

What are the main financial stats of BMY
Market
Shares outstanding
2.13B
Market cap
$153.93B
Enterprise value
$185.3B
Valuations
Price to earnings (P/E)
23.43
Price to book (P/B)
4.73
Price to sales (P/S)
3.31
EV/EBIT
24.07
EV/EBITDA
10.28
EV/Sales
3.96
Earnings
Revenue
$46.74B
EBIT
$7.7B
EBITDA
$18.03B
Free cash flow
$12.73B
Per share
EPS
$3.09
Free cash flow per share
$5.96
Book value per share
$15.3
Revenue per share
$21.89
TBVPS
$18.22
Balance sheet
Total assets
$98.2B
Total liabilities
$65.46B
Debt
$39.1B
Equity
$32.67B
Working capital
$7.87B
Liquidity
Debt to equity
1.2
Current ratio
1.42
Quick ratio
0.98
Net debt/EBITDA
1.74
Margins
EBITDA margin
38.6%
Gross margin
78.8%
Net margin
14.3%
Operating margin
16.5%
Efficiency
Return on assets
6.5%
Return on equity
20.1%
Return on invested capital
14.6%
Return on capital employed
9.7%
Return on sales
16.5%
Dividend
Dividend yield
3.02%
DPS
$2.19
Payout ratio
70.9%

BMY stock price

How has the Bristol Myers Squibb stock price performed over time
Intraday
-0.07%
1 week
-1.17%
1 month
0.63%
1 year
11.54%
YTD
0.63%
QTD
0.63%

Financial performance

How have Bristol Myers Squibb's revenue and profit performed over time
Revenue
$46.74B
Gross profit
$36.84B
Operating income
$7.71B
Net income
$6.68B
Gross margin
78.8%
Net margin
14.3%
Bristol Myers Squibb's gross profit has increased by 5% YoY
The company's revenue rose by 2.8% YoY
BMY's net margin is up by 2.1% since the previous quarter
The gross margin has increased by 2.5% YoY

Growth

What is Bristol Myers Squibb's growth rate over time

Valuation

What is Bristol Myers Squibb stock price valuation
P/E
23.43
P/B
4.73
P/S
3.31
EV/EBIT
24.07
EV/EBITDA
10.28
EV/Sales
3.96
Bristol Myers Squibb's equity has decreased by 12% YoY
BMY's P/B is 3% above its 5-year quarterly average of 4.6 and 3% above its last 4 quarters average of 4.6
The price to sales (P/S) is 8% less than the 5-year quarterly average of 3.6
The company's revenue rose by 2.8% YoY

Efficiency

How efficient is Bristol Myers Squibb business performance
Bristol Myers Squibb's ROA has increased by 4.8% from the previous quarter
The ROE has grown by 4.1% from the previous quarter
BMY's return on invested capital is up by 2.8% since the previous quarter

Dividends

What is BMY's dividend history
DPS
$2.19
Dividend yield
3.02%
Payout ratio
70.9%
Recent dividends

Financial health

How did Bristol Myers Squibb financials performed over time
BMY's total assets is 50% greater than its total liabilities
The quick ratio has decreased by 16% YoY and by 8% QoQ
The total liabilities has declined by 11% year-on-year and by 3.3% since the previous quarter
BMY's debt is 20% greater than its equity
BMY's debt is down by 13% year-on-year and by 7% since the previous quarter
Bristol Myers Squibb's equity has decreased by 12% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.